Omeros: Pay

Omeros paid its 3 named executives $5.8M in total in FY2025 (Dec). CEO Gregory A. Demopulos, M.D. was paid $4.2M of that.

Pay$100 in the stock at the end of FY20 → $120
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Gregory A. Demopulos, M.D.President, Chief Executive Officer and Chairman of the Board
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
FY2021 (Dec)
5 years
Peter B. Cancelmo, J.D.Vice President, General Counsel and Secretary
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)
FY2021 (Dec)
5 years
David J. BorgesVice President, Finance, Chief Accounting Officer and Treasurer
FY2025 (Dec)
FY2024 (Dec)
2 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 7 peers with pay on file was $3.4M. CEO pay of Omeros for that year is not on file.

  1. 1Arcus Biosciences
  2. 2Agios Pharmaceuticals
  3. 3Vanda Pharmaceuticals
  4. 4Aclaris Therapeutics
  5. 5Enanta Pharmaceuticals
  6. 6Ironwood Pharmaceuticals
  7. 7Collegium Pharmaceutical
  8. 8OmerosNot disclosed
  9. 9Coherus BioSciences, Inc.Not disclosed
  10. 10Esperion Therapeutics, Inc.Not disclosed
  11. 11Karyopharm Therapeutics Inc.Not disclosed
  12. 12Mersana Therapeutics, Inc.Not disclosed
  13. 13Pacira BioSciencesNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.